John Woolford | Investor Relations, Westwicke |
Daniel O'Connell | President & Chief Executive Officer |
Eric Siemers | Chief Medical Officer |
Matt Zuga | Chief Financial Officer & Chief Business Officer |
Judah Frommer | Credit Suisse |
Tom Shrader | BTIG |
Ting Liu | UBS |
Good day. Thank you for standing by, and welcome to the Acumen Pharmaceuticals, Second Quarter 2022 Update Call. At this time, all participants are in a listen-only mode. There'll be a brief overview followed by a question-and-answer session. [Operator Instructions] Today's call is being recorded.